COSMIC-313 lay summary Information on Kidney Cancer Study of Nivolumab + Ipilimumab Versus Nivolumab Alone – lay summary More from the InfoHUB InfoHub (6) Topics (25) Decision aids (1) Factsheets (9) Graphics (2) Guidelines (1) Publications (9) Karin Kastrati2019-08-09T09:42:39+02:00August 7th, 2019|Uncategorised|
